INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.330
+0.065 (5.14%)
At close: Mar 6, 2026, 4:00 PM EST
1.300
-0.030 (-2.26%)
After-hours: Mar 6, 2026, 7:24 PM EST
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $35.36 million as of March 6, 2026. Its market cap has decreased by -83.20% in one year.
Market Cap
35.36M
Enterprise Value
8.70M
1-Year Change
-83.20%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $35.36M, a decrease of -54.57%. That is a compound annual growth rate of -10.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 33.63M | -18.91% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBay Pharmaceuticals | 38.14M |
| Lisata Therapeutics | 38.02M |
| Tvardi Therapeutics | 37.71M |
| Tevogen Bio Holdings | 37.52M |
| CervoMed | 37.20M |
| AN2 Therapeutics | 36.72M |
| Outlook Therapeutics | 36.42M |
| Celularity | 36.05M |